Tasly Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001C81
CNY
13.63
-0.52 (-3.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,925.80
2,022.46
2,233.32
2,054.89
2,035.58
2,090.82
2,323.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,925.80
2,022.46
2,233.32
2,054.89
2,035.58
2,090.82
2,323.08
Raw Material Cost
692.45
729.53
754.57
727.57
695.09
771.39
793.28
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.44
7.28
7.32
12.45
1.07
10.15
19.81
Selling and Distribution Expenses
788.73
827.21
857.10
799.00
861.12
811.19
838.29
Other Expenses
9.94
17.59
10.69
16.50
23.56
15.56
12.35
Total Expenditure (Excl Depreciation)
1,586.06
1,739.88
1,725.92
1,704.00
1,792.84
1,748.31
1,774.84
Operating Profit (PBDIT) excl Other Income
339.7
282.6
507.40000000000003
350.90000000000003
242.7
342.5
548.2
Other Income
52.84
49.52
32.66
66.37
50.30
44.06
46.73
Operating Profit (PBDIT)
366.60
421.18
613.18
503.74
188.86
443.33
686.06
Interest
5.44
7.28
7.32
12.45
1.07
10.15
19.81
Exceptional Items
130.75
-14.38
35.43
42.18
42.58
-83.90
-83.78
Gross Profit (PBDT)
1,233.35
1,292.93
1,478.76
1,327.32
1,340.49
1,319.43
1,529.81
Depreciation
118.92
118.92
113.38
113.38
124.30
124.30
126.94
Profit Before Tax
372.99
280.60
527.90
420.08
106.06
224.98
455.52
Tax
123.68
45.36
38.97
75.88
41.21
28.89
58.13
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
120.59
209.68
460.39
314.31
113.38
179.89
367.10
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
120.59
209.68
460.39
314.31
113.38
179.89
367.10
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-51.80
-6.90
-2.70
17.78
-82.47
-4.76
-7.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
68.78
202.77
457.69
332.08
30.91
175.13
360.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
12,404.23
12,304.42
12,377.39
11,919.98
11,903.33
12,706.97
12,531.09
Earnings per share (EPS)
0.08
0.14
0.31
0.21
0.08
0.12
0.25
Diluted Earnings per share
0.08
0.14
0.31
0.21
0.08
0.12
0.25
Operating Profit Margin (Excl OI)
10.12%
12.5%
20.92%
15.77%
0.7%
13.15%
22.06%
Gross Profit Margin
25.54%
19.75%
28.71%
25.96%
11.32%
16.71%
25.07%
PAT Margin
6.26%
10.37%
20.61%
15.3%
5.57%
8.6%
15.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -4.78% vs -9.44% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -66.07% vs -55.69% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -15.58% vs -35.97% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -26.03% vs 0.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Tasly Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,925.80
0
1,925.80
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,925.80
0
1,925.80
Raw Material Cost
692.45
0
692.45
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.44
0
5.44
Selling and Distribution Expenses
788.73
0
788.73
Other Expenses
9.94
0.00
9.94
Total Expenditure (Excl Depreciation)
1,586.06
0
1,586.06
Operating Profit (PBDIT) excl Other Income
339.75
0.00
339.75
Other Income
52.84
0
52.84
Operating Profit (PBDIT)
366.60
0
366.60
Interest
5.44
0
5.44
Exceptional Items
130.75
0
130.75
Gross Profit (PBDT)
1,233.35
0
1,233.35
Depreciation
118.92
0
118.92
Profit Before Tax
372.99
0
372.99
Tax
123.68
0
123.68
Provisions and contingencies
0
0
0.00
Profit After Tax
120.59
0
120.59
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
120.59
0
120.59
Share in Profit of Associates
0
0
0.00
Minority Interest
-51.80
0
-51.80
Other related items
0.00
0.00
0.00
Consolidated Net Profit
68.78
0
68.78
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
12,404.23
0
12,404.23
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
10.12%
0%
0.00
10.12%
Gross Profit Margin
25.54%
0%
0.00
25.54%
PAT Margin
6.26%
0%
0.00
6.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 192.58 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -4.78% vs -9.44% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -5.39% vs -3.19% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.88 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -66.07% vs -55.69% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 122.65% vs 89.57% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 31.38 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -15.58% vs -35.97% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 126.41% vs -45.52% in Dec 2024

Quarterly - Interest
Interest 0.54 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -26.03% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 390.91% vs -92.95% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.12%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024